1. Signaling Pathways
  2. Metabolic Enzyme/Protease
  3. Cytochrome P450

Cytochrome P450

CYPs

Cytochrome p450 comprises a superfamily of heme-thiolate proteins named for the spectral absorbance peak of their carbon-monoxide-bound species at 450 nm. Having been found in every class of organism, including Archaea, the p450 superfamily is believed to have originated from an ancestral gene that existed over 3 billion years ago. Repeated gene duplications have subsequently given rise to one of the largest of multigene families. These enzymes are notable both for the diversity of reactions that they catalyze and the range of chemically dissimilar substrates upon which they act. Cytochrome p450s support the oxidative, peroxidative and reductive metabolism of such endogenous and xenobiotic substrates as environmental pollutants, agrochemicals, plant allelochemicals, steroids, prostaglandins and fatty acids. In humans, Cytochrome p450s are best known for their central role in phase I drug metabolism where they are of critical importance to two of the most significant problems in clinical pharmacology: drug interactions and interindividual variability in drug metabolism.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-119996
    AR-C141990
    Inhibitor
    AR-C141990 (Compound 30) is a potent blocker of the monocarboxylate transporter MCT1 with a Ki of 4.8 nM. AR-C141990 (Compound 30) inhibits CYP3A4 and CYP2C9 with IC50 values of 16 μM.
    AR-C141990
  • HY-A0064R
    Verapamil (hydrochloride) (Standard)
    Inhibitor
    Verapamil (hydrochloride) (Standard) is the analytical standard of Verapamil (hydrochloride). This product is intended for research and analytical applications. Verapamil hydrochloride ((±)-Verapamil hydrochloride) is a calcium channel blocker and a potent and orally active first-generation P-glycoprotein (P-gp) inhibitor. Verapamil hydrochloride also inhibits CYP3A4. Verapamil hydrochloride has the potential for high blood pressure, heart arrhythmias and angina research.
    Verapamil (hydrochloride) (Standard)
  • HY-E70504
    Human CYP2B6,Low-Reductase+b5
    Human CYP2B6, Low-Reductase+b5, a recombinant CYP2B6, is a member of the CYP enzyme family. CYP2B6 is an anti-obesity enzym, playing a role in the metabolism of numerous xeno- and endobiotic compounds.
    Human CYP2B6,Low-Reductase+b5
  • HY-151119
    Anticancer agent 78
    Inhibitor
    Anticancer agent 78 is a potent anticancer agent. Anticancer agent 78 shows cytotoxicity. Anticancer agent 78 exhibits anti-aromatase activity with an IC50 value of 0.9 µM. Anticancer agent 78 has the potential for the research of breast cancer.
    Anticancer agent 78
  • HY-E70495
    Human CYP2C8,Low-Reductase+b5
    Human CYP2C8, ,Low-Reductase+b5, a recombinant CYP2C8, is a member of the CYP enzyme family and is involved in the metabolism of xenobiotics in the body.
    Human CYP2C8,Low-Reductase+b5
  • HY-150574
    CYP3A4-IN-1
    Inhibitor
    CYP3A4-IN-1 (compound 5a) is a potent cytochrome P450 3A4 (CYP3A4) inhibitor with an IC50 value of 0.085 µM.
    CYP3A4-IN-1
  • HY-113482
    1β-Hydroxydeoxycholic acid
    1β-Hydroxydeoxycholic acid (1β-OH-DCA), a secondary bile acid, is a CYP3A biomarker. Deoxycholic acid is specifically metabolized into 1β-Hydroxydeoxycholic acid by CYP3A4 and CYP3A7 using recombinant human CYP450 enzymes.
    1β-Hydroxydeoxycholic acid
  • HY-144643
    CYP51/HDAC-IN-1
    Inhibitor
    CYP51/HDAC-IN-1 is a potent, orally active CYP51/HDAC dual inhibitor. CYP51/HDAC-IN-1 inhibits important virulence factors and down-regulated resistance-associated genes. CYP51/HDAC-IN-1 exhibits potent therapeutic effects for both tropical candidiasis and cryptococcal meningitis.
    CYP51/HDAC-IN-1
  • HY-122410R
    Dihydrolanosterol (Standard)
    Citraconic acid (Standard) is the analytical standard of Citraconic acid. This product is intended for research and analytical applications. Citraconic acid belongs to the class of organic compounds known as methyl-branched fatty acids.
    Dihydrolanosterol (Standard)
  • HY-E70474
    Human CYP2B6,High-Reductase
    Human CYP2B6, High-Reductase, a recombinant CYP2B6, is a member of the CYP enzyme family. CYP2B6 is an anti-obesity enzym, playing a role in the metabolism of numerous xeno- and endobiotic compounds.
    Human CYP2B6,High-Reductase
  • HY-N10191
    Hydroaurantiogliocladin
    Hydroaurantiogliocladin is a quinol. Hydroaurantiogliocladin can be used as substrate for the quinol-cytochrome c oxidoreductase activity (beef heart enzyme).
    Hydroaurantiogliocladin
  • HY-E70499
    Human CYP4F3,High-Reductase
    Human CYP4F3, High-Reductase, a recombinant CYP4F3, is a member of the CYP enzyme family. CYP4F3 is an enzyme mainly expressed in polymorphonuclear leukocytes.
    Human CYP4F3,High-Reductase
  • HY-N0693R
    Schisandrin A (Standard)
    Inhibitor
    Schisandrin A (Standard) is the analytical standard of Schisandrin A. This product is intended for research and analytical applications. Schisandrin A inhibits CYP3A activity with an IC50 of 6.60 μM and Ki of 5.83 μM, respectively.
    Schisandrin A (Standard)
  • HY-112690
    Pradefovir
    Pradefovir is a good substrate for liver CYP3A4. Pradefovir is converted to 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in human liver microsomes with a Km of 60 μM.
    Pradefovir
  • HY-E70482
    Human CYP2J2,Low-Reductase
    Human CYP2J2, Low-Reductase, a recombinant CYP2J2, is a member of the CYP enzyme family. Human CYP2J2, Low-Reductase is the most abundant epoxygenase in the heart and has multifunctional properties.
    Human CYP2J2,Low-Reductase
  • HY-N1282R
    Seneciphylline (Standard)
    Inhibitor
    Seneciphylline (Standard) is the analytical standard of Seneciphylline. This product is intended for research and analytical applications. Seneciphylline is a toxic pyrrolizidine alkaloid in Gynura japonica. Seneciphylline significantly increases the activities of epoxide hydrase and glutathione-S-transferase but causes reduction of cytochrome P-450 and related monooxygenase activities.
    Seneciphylline (Standard)
  • HY-B1812S3
    Veratrole-d6
    Substrate
    Veratrole-d6 is the deuterium labeled Veratrole. Veratrole (1,2-Dimethoxybenzene) is a key compound that widely exists in plants and attracts pollinators. The release of Veratrole has a circadian rhythm and plays an important role in plant reproduction, species differentiation, and interactions with pollinators. In addition, Veratrole can be demethylated by cytochrome P-450 in Streptomyces setonii.
    Veratrole-d<sub>6</sub>
  • HY-13632S1
    Exemestane-13C3
    Inhibitor
    Exemestane-13C3 is the 13C-labeled Exemestane. Exemestane (FCE 24304) is a selective, irreversible and orally active steroidal aromatase inhibitor with IC50s of 30 nM and 40 nM for human placental and rat ovarian aromatase, respectively. Exemestane can be used for hormone-dependent breast cancer research[1][2].
    Exemestane-<sup>13</sup>C<sub>3</sub>
  • HY-W008226R
    Phloracetophenone (Standard)
    Activator
    Oxprenolol (hydrochloride) (Standard) is the analytical standard of Oxprenolol (hydrochloride). This product is intended for research and analytical applications. Oxprenolol hydrochloride (Ba 39089) is an orally bioavailable β-adrenergic receptor (β-AR) antagonist with a Ki of 7.10 nM in a radioligand binding assay using rat heart muscle.
    Phloracetophenone (Standard)
  • HY-116601
    6-Hydroxywarfarin
    6-Hydroxywarfarin is a metabolite of (+) -warfarin. 6-Hydroxywarfarin is a weaker vitamin K antagonist. 6-Hydroxywarfarin is metabolized by the cytochrome P450 isomer 2C9 (CYP2C9).
    6-Hydroxywarfarin
Cat. No. Product Name / Synonyms Application Reactivity

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.